Valeant Pharmaceuticals Stock Rating Reaffirmed by Ubs Ag

Home › Valeant Pharmaceuticals Stock Rating Reaffirmed by Ubs Ag

's stock had its "buy" rating reaffirmed by stock analysts at UBS AG in a report issued on Tuesday, StockRatingsNetwork reports.

07.11	Ralco acquires Sow Magic
07.11	H5N1 pigs likely became infected from contact with migratory birds
07.11	BioMADE Announces $26.9 Million Invested in 17 Projects
07.11	Hurricane Rafael Graphics
07.11	Hurricane Rafael Public Advisory Number 15A
07.11	Summary for Hurricane Rafael (AT3/AL182024)
07.11	Atlantic Tropical Weather Outlook
07.11	Eastern North Pacific Tropical Weather Outlook
More »

je.st